Daily non-political popular news in brief.

Lowering body temperature could aid standard stroke treatment

05-17-2007 · EurekAlert!

University of Cincinnati scientists have developed a model that could help physicians combine current clot-busting medication with below-normal body temperatures (hypothermia) to improve the treatment of ischemic stroke patients.

Keywords: lowering, body, temperature, aid, standard, stroke, treatment

« Previous | Next »

Similar news on "Lowering body temperature could aid standard stroke treatment":

Cause of nerve fiber damage in multiple sclerosis identified
10-16-2006 · EurekAlert!
Researchers have identified how the body's own immune system contributes to the nerve fiber damage caused by multiple sclerosis, a finding that can potentially aid earlier diagnosis and improved treatment for this chronic disease.
Similar news · Read more »
Standard treatment for prostate cancer may encourage spread of disease
10-01-2007 · EurekAlert!
A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests.
Similar news · Read more »
Perchance to Hibernate
01-27-2007 · Science News Online
As scientists work to unravel the secrets of mammalian hibernation, they're eyeing medical applications that could aid wounded soldiers, stroke victims, and transplant recipients, among others.
Similar news · Read more »
Natural immune-control system may aid treatment of autoimmune disease and tissue rejection
05-17-2007 · EurekAlert!
The immune system’s ability to police itself may offer a new method of arresting the cells responsible for autoimmune diseases such as multiple sclerosis and for the rejection of transplanted organs and tissues, report scientists at Dana-Farber Cancer Institute.
Similar news · Read more »
Fantastic Voyage: A New Nanoscale View Of The Biological World
10-06-2006 · ScienceDaily
Echoing the journey through the human body in "Fantastic Voyage," doctors might soon be able to track individual donor cells after a transplant, or to find where and how much of a cancer treatment drug there is within a cell. New technology described in a study published in the open access journal, Journal of Biology makes it possible to image and quantify molecules within individual mammalian or bacterial cells.
Similar news · Read more »
Scientist warns marathon runners: Water won't help you keep your cool
04-21-2007 · EurekAlert!
A research team led by the University of Exeter has found that fluid intake does not affect body temperature in runners. Therefore, runners in today's London Marathon will not improve their performance by drinking more water.
Similar news · Read more »
Mouse model points to possible new strategy for treating rare muscle disease, kidney disorders
06-01-2007 · EurekAlert!
Based on clues provided by a study with transgenic mice, a research group at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has developed a strategy that will be tested as the first treatment for people with hereditary inclusion body myopathy (HIBM), a rare, degenerative muscle disease. In an unexpected finding, the research indicates that the approach also might benefit patients with certain kidney disorders.
Similar news · Read more »
University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels
01-09-2008 · EurekAlert!
Medical researchers at the University of Alberta in Edmonton, Canada have found a way to reduce the amount of bad cholesterol and fatty acids that end up in the blood from food the body metabolizes, a key discovery that could lead to new drugs to treat and reverse the effects of diabetes and heart disease related to obesity. Existing drugs called statins are used to lower cholesterol, but do not treat obesity or diabetes.
Similar news · Read more »
Benefit of exenatide has not yet been proven
10-17-2007 · EurekAlert!
Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta), which is marketed by the manufacturer Eli Lilly. According to current evidence, the blood-glucose lowering effect of exenatide has been demonstrated, but is not superior to the corresponding effect of insulin. Moreover, there is no evidence to show that the improved glycaemic control contributes to a reduction in the rate of late complications of diabetes.
Similar news · Read more »
Enhancing chemotherapy's efficacy: new agent has synergistic effect with standard drugs
04-15-2007 · EurekAlert!
Integrating the use of drugs targeted to specific cancer proteins into current chemotherapy regimens to improve the efficacy of systemic treatment is an important clinical goal. Fox Chase Cancer Center research presented during AACR has found that a new chemical agent, MCP110, has a synergistic effect both in vitro and in vivo when used with current chemotherapy drugs such as taxanes (Taxol and Taxotere) and vinca-alkaloid compounds such as vincristine.
Similar news · Read more »